iBio Inc (IBIO)
1.66
0.00 (0.00%)
USD |
NYAM |
Apr 30, 14:23
iBio Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.05M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 1.80M |
| December 31, 2021 | |
| September 30, 2021 | 0.084M |
| June 30, 2021 | 0.491M |
| March 31, 2021 | 0.765M |
| December 31, 2020 | 0.705M |
| September 30, 2020 | 0.41M |
| June 30, 2020 | 1.12M |
| March 31, 2020 | 0.096M |
| December 31, 2019 | 0.314M |
| September 30, 2019 | 0.108M |
| June 30, 2019 | 0.795M |
| March 31, 2019 | 0.527M |
| December 31, 2018 | 0.651M |
| September 30, 2018 | 0.045M |
| June 30, 2018 | 0.091M |
| March 31, 2018 | 0.078M |
| December 31, 2017 | 0.153M |
| September 30, 2017 | 0.122M |
| Date | Value |
|---|---|
| June 30, 2017 | 0.147M |
| March 31, 2017 | 0.037M |
| December 31, 2016 | 0.075M |
| September 30, 2016 | 0.135M |
| June 30, 2016 | 0.275M |
| March 31, 2016 | 0.379M |
| December 31, 2015 | 0.134M |
| September 30, 2015 | 0.16M |
| June 30, 2015 | 0.316M |
| March 31, 2015 | 0.349M |
| December 31, 2014 | 0.367M |
| September 30, 2014 | 0.819M |
| June 30, 2014 | 0.205M |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | 0.617M |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | 0.39M |
| June 30, 2012 | 0.3511M |
| March 31, 2012 | 0.3718M |
| December 31, 2011 | 0.2338M |
| September 30, 2011 | 0.3203M |
| June 30, 2011 | 0.3441M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.05M
Minimum
Sep 2023
1.80M
Maximum
Mar 2022
0.5615M
Average
0.4505M
Median
Revenue (Quarterly) Benchmarks
| Lixte Biotechnology Holdings Inc | -- |
| PAVmed Inc | 1.049M |
| Avalo Therapeutics Inc | 0.571M |
| Imunon Inc | -- |
| Ocugen Inc | 6.036M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.211M |
| Total Expenses (Quarterly) | 4.496M |
| EPS Diluted (Quarterly) | -4.42 |
| Enterprise Value | 15.65M |
| Earnings Yield | -904.8% |
| Normalized Earnings Yield | -2225.30 |